檢索結果 - Raghav Sundar

Refine Results
  1. 1
    Combining DNA damaging therapeutics with immunotherapy: more haste, less speed

    Combining DNA damaging therapeutics with immunotherapy: more haste, less speed 由 Jessica Brown, Raghav Sundar, Juanita Lopez

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Immune checkpoint inhibitor combinations—current and emerging strategies

    Immune checkpoint inhibitor combinations—current and emerging strategies 由 Robert J. Walsh, Raghav Sundar, Joline S.J. Lim

    出版 2023
    獲取全文 獲取全文
    Editorial
    加到收藏夾
    Saved in:
  3. 3
    Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers

    Predictive Biomarkers of Immune Checkpoint Inhibition in Gastroesophageal Cancers 由 Raghav Sundar, Elizabeth Smyth, Siyu Peng, Joe Yeong, Patrick Tan

    出版 2020
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Nivolumab in NSCLC: latest evidence and clinical potential

    Nivolumab in NSCLC: latest evidence and clinical potential 由 Raghav Sundar, Byoung Chul Cho, Julie R. Brahmer, Ross A. Soo

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Biomarkers for Homologous Recombination Deficiency in Cancer

    Biomarkers for Homologous Recombination Deficiency in Cancer 由 Michal Marek Hoppe, Raghav Sundar, David S.P. Tan, Anand D. Jeyasekharan

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    Immunotherapy in the treatment of non-small cell lung cancer

    Immunotherapy in the treatment of non-small cell lung cancer 由 Raghav Sundar, Richie Soong, Byoung Chul Cho, Julie R. Brahmer, Ross A. Soo

    出版 2014
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  7. 7
    Frailty and long-term survival among patients in Australian intensive care units with metastatic cancer (FRAIL-CANCER study): a retrospective registry-based cohort study

    Frailty and long-term survival among patients in Australian intensive care units with metastatic cancer (FRAIL-CANCER study): a retrospective registry-based cohort study 由 Muhammad Alamgeer, Ryan Ruiyang Ling, Ryo Ueno, Krishnaswamy Sundararajan, Raghav Sundar, David Pilcher, Ashwin Subramaniam

    出版 2023
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and Treatment

    Artificial Intelligence in Clinical Oncology: From Data to Digital Pathology and Treatment 由 Kirthika Senthil Kumar, Vanja Mišković, Agata Blasiak, Raghav Sundar, Alessandra Pedrocchi, Alexander T. Pearson, Arsela Prelaj, Dean Ho

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma

    Effectiveness of Immune Checkpoint Inhibitors in Patients With Advanced Esophageal Squamous Cell Carcinoma 由 Dominic Wei Ting Yap, Alberto Giovanni Leone, Nicky Zhun Hong Wong, Joseph J. Zhao, Jeremy Tey, Raghav Sundar, Filippo Pietrantonio

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  10. 10
    Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer

    Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer 由 Raghav Sundar, Kie Kyon Huang, Aditi Qamra, K.-M. Kim, S.T. Kim, Won Ki Kang, Angie Tan, J. Lee, Patrick Tan

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Neoadjuvant therapy in locally advanced colon cancer: a meta-analysis and systematic review

    Neoadjuvant therapy in locally advanced colon cancer: a meta-analysis and systematic review 由 Chin Kai Cheong, Kameswara Rishi Yeshayahu Nistala, Cheng Han Ng, Nicholas Syn, Heidi Sian Ying Chang, Raghav Sundar, Soon Yu Yang, Choon Seng Chong

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis

    Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis 由 Yong Xiang Gwee, Daryl Kai Ann Chia, Jimmy Bok Yan So, Wim Ceelen, Wei Peng Yong, Patrick Tan, Chin‐Ann Johnny Ong, Raghav Sundar

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Low Programmed Death-Ligand 1–Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma

    Low Programmed Death-Ligand 1–Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma 由 Joseph J. Zhao, Dominic Wei Ting Yap, Yiong Huak Chan, Benjamin Kye Jyn Tan, Chong Boon Teo, Nicholas Syn, Elizabeth Smyth, Yu Yang Soon, Raghav Sundar

    出版 2021
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  14. 14
    Low‐dose pembrolizumab in the treatment of advanced non‐small cell lung cancer

    Low‐dose pembrolizumab in the treatment of advanced non‐small cell lung cancer 由 Jia Li Low, Yiqing Huang, Kenneth Sooi, Yvonne Ang, Zhi Yao Chan, Katie Spencer, Anand D. Jeyasekharan, Raghav Sundar, Boon Cher Goh, Ross A. Soo, Wei Peng Yong

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy

    Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients rece... 由 Alex Molassiotis, Huilin Cheng, Violeta López, Joseph S. K. Au, Alexandre Chan, Aishwarya Bandla, Kwun To Leung, Y. C. Li, Ka‐Hing Wong, Lorna Kwai Ping Suen, Choi Wan Chan, Janelle Yorke, Carole Farrell, Raghav Sundar

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy

    Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy 由 Alex Molassiotis, Huilin Cheng, Kwun To Leung, Yu Chung Li, Kam Hung Wong, Joseph S. K. Au, Raghav Sundar, Alexandre Chan, Terrence Rong De Ng, Lorna Kwai Ping Suen, Choi Wan Chan, Janelle Yorke, Violeta López

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases

    PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases 由 Guowei Kim, Hon Lyn Tan, Raghav Sundar, Bettina Lieske, Cheng Ean Chee, Jingshan Ho, Asim Shabbir, Maria V. Babak, Wee Han Ang, Boon Cher Goh, Wei Peng Yong, Lingzhi Wang, Jimmy Bok Yan So

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination

    Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination 由 Raghav Sundar, Drolaiz Hw Liu, Gordon G.A. Hutchins, Hayley Slaney, Arnaldo N. S. Silva, Jan Oosting, Jeremy D. Hayden, Lindsay C. Hewitt, Cedric Chuan Young Ng, Amrita Mangalvedhekar, Sarah Ng, Iain Tan, Patrick Tan, Heike I. Grabsch

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis

    Efficacy of COVID-19 vaccines in immunocompromised patients: A systematic review and meta-analysis 由 Ainsley Ryan Yan Bin Lee, Shi Yin Wong, Louis Yi Ann Chai, Soo Chin Lee, Matilda Lee, Mark Muthiah, Sen Hee Tay, Chong Boon Teo, Benjamin Kye Jyn Tan, Yiong Huak Chan, Raghav Sundar, Yu Yang Soon

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  20. 20
    Dynamic, personalized dose selection platform, CURATE.AI, in patients with solid tumors: case series and pilot feasibility trial

    Dynamic, personalized dose selection platform, CURATE.AI, in patients with solid tumors: case series and pilot feasibility trial 由 Raghav Sundar, Agata Blasiak, Anh T. L. Truong, Lester W. J. Tan, Kirthika Senthil Kumar, Shi‐Bei Tan, Chong Boon Teo, Benjamin Y. L. Tan, Xavier Tadeo, Hon Lyn Tan, Cheng Ean Chee, Wei Peng Yong, Dean Ho

    出版 2024
    獲取全文 獲取全文
    Pré-impressão
    加到收藏夾
    Saved in:

檢索工具: